SANGSTAT
SangStat Medical Corporation, a global biopharmaceutical company, engages in the discovery, development, and marketing of therapeutic products for immunology, transplantation medicine, hematology/oncology, and autoimmune disorders.
SANGSTAT
Industry:
Biotechnology Manufacturing Medical
Founded:
1988-01-01
Address:
Fremont, California, United States
Country:
United States
Status:
Active
Contact:
(510) 789-4300
Similar Organizations
Biorthex
Biorthex designs, develops, manufactures and markets innovative and proprietary surgical products for the treatment of spinal disorders.
NUCRYST Pharmaceuticals
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using
RITA Medical Systems, Inc
RITA Medical Systems develops, manufactures and markets innovative products for patients with solid cancerous or benign tumors.
Current Employees Featured
Founder
More informations about "SangStat"
SangStat - Crunchbase Company Profile & Funding
SangStat Medical Corporation, a global biopharmaceutical company, engages in the discovery, development, and marketing of therapeutic products for …See details»
Organization | Sangstat Medical Corporation - Purdue University
Organization Overview. First Clinical Trial. 1999 NCT00035880. First Marketed Drug. None First NDA Approval. None Last Known Activity ... SangStat Medical Active Ingredients. Drugs in …See details»
SangStat Medical Company Profile 2025: Valuation, Investors ...
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-7498309-B2: Containing a suspending agent (oleoyl macrogol glyceride), and a dispersant (silica sol); …See details»
SangStat Medical Corporation Information - RocketReach
SangStat is a global biotechnology company focused on immunology and working to discover, develop and market high value therapeutic products in the autoimmune, hematology/oncology …See details»
SangStat Medical Corp.: Drug pipelines, Patents, Clinical trials
Aug 5, 2023 Explore SangStat Medical Corp. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news, and 29 literature, Drug:Allotrap 07, Gavilimomab.See details»
SANGSTAT MEDICAL CORPORATION - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SANGSTAT MEDICAL CORPORATION of Framingham, MA. Get the latest business insights from Dun & …See details»
Welcome to ceocfointerviews.com!
SangStat also maintains a strong European presence, including direct sales and marketing forces in France, Germany, Italy, Spain, and the U.K., and distributors throughout the rest of the …See details»
SangStat - Crunchbase
Organization. SangStat . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. SangStat Medical, …See details»
Sangstat - Drug Targets, Indications, Patents - Synapse
Sangstat, Initially developed by National Heart, Lung & Blood Institute, Now, its global highest R&D status is Pending, Therapeutic Areas: Immune System Diseases,Congenital …See details»
SangStat - Updates, News, Events, Signals & Triggers - Crunchbase
SangStat Medical develops, manufactures and markets a family of Bio-Pharmaceutical products which serve the organ transplantation market. Search Crunchbase Start Free TrialSee details»
SangStat Medical Corporation - Wikidata
SangStat Medical Corporation (Q30280356) From Wikidata. Jump to navigation Jump to search. healthcare organization in Fremont, United States. edit. Language Label Description Also …See details»
SANGSTAT MEDICAL CORP Top 13F Holdings - WhaleWisdom.com
Sangstat Medical Corp is based out of Fremont. SangStat Medical Corporation's principal activities are to discover, develop and market high value therapeutic products in immunology, …See details»
SangStat Medical Corporation - finchat.io
Browse financials, filings, estimates, and much more for SangStat Medical Corporation (SANG).See details»
SangStat shares jump on news of buyout / Genzyme to acquire
Aug 5, 2003 SangStat Chief Executive Officer Richard Murdock said the purchase is a good deal for employees as well as shareholders. Murdock said SangStat alone might have struggled to …See details»
In Brief: SangStat - Medtech Insight
May 22, 1995 SangStat: Receives 510(k) clearance for Cross-Stat, a monitoring assay that uses the firm's patented soluble human leukocyte antigen (sHLA) technology to help identify …See details»
Genzyme acquires SangStat - 2003-09-10 - Crunchbase
Acquired Organization: SangStat SangStat Medical develops, manufactures and markets a family of Bio-Pharmaceutical products which serve the organ transplantation market. Acquiring …See details»
In Brief: SangStat's CycloTech - insights.citeline.com
SangStat's CycloTech: Cyclosporine dose-management system increases transplant patient compliance with dosing regimens of the immunosuppressive drug, the company maintains at a …See details»
Nationwide Recall of SangCya Oral Solution - JAMA Network
CONSERVE 2021 Guidelines for Reporting Trials Modified for the COVID-19 Pandemic Creation and Adoption of Large Language Models in Medicine Global Burden of Cancer, 2010-2019 …See details»
SangStat - Contacts, Employees, Board Members, Advisors & Alumni
Organization. SangStat . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. SangStat has 1 current employee profile, …See details»
Sangstat Medical Corp 13F Hedge Fund and Asset Management …
View 13F filing holders of Sangstat Medical Corp. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managersSee details»